- Rare disease commercial veteran Mr. Grabow to lead Immix’s U.S. launch and commercial buildout for NXC-201 in relapsed/refractory AL Amyloidosis, a serious, rare, blood disease with no currently ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback